Latest News in the pharma Industry

Market News

Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

25 May 2017

First clinical study using a patent protected minocycline API and formulation developed by Hovione.

Read more 
PharmaMar and Eczacıbaşı sign a licensing agreement for Aplidin in Turkey

PharmaMar and Eczacıbaşı sign a licensing agreement for Aplidin in Turkey

25 May 2017

Aplidin is PharmaMar's second most advanced anticancer drug currently under development for the treatment of multiple myeloma and angioimmunoblastic T-cell lymphoma.

Read more 
Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

25 May 2017

Strengthens pipeline with lead candidate TNT009 in cold agglutinin disease, a rare and chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
FDA approves Kevzara for the treatment of moderately to severely active RA in adults

FDA approves Kevzara for the treatment of moderately to severely active RA in adults

23 May 2017

Kevzara is now available to US patients.

Read more 
Thermo Fisher Scientific to acquire Patheon

Thermo Fisher Scientific to acquire Patheon

22 May 2017

Patheon provides entry into the attractive, high-growth CDMO market.

Read more 
Boehringer Ingelheim inaugurates biopharmaceutical manufacturing facility in China

Boehringer Ingelheim inaugurates biopharmaceutical manufacturing facility in China

22 May 2017

It is the first and only biopharmaceutical manufacturing site established by a multinational active pharmaceutical company in China.

Read more 
Hikma launches generic version on Edecrin in the US market

Hikma launches generic version on Edecrin in the US market

20 May 2017

Product adds to the company's non-injectables portfolio in the US.

Read more 
Biogen acquires Remedy Pharmaceuticals’ Cirara for large hemispheric stroke

Biogen acquires Remedy Pharmaceuticals’ Cirara for large hemispheric stroke

19 May 2017

Phase III-ready program complements Biogen’s ongoing development efforts in stroke.

Read more 
Irvine Scientific launches new xeno-free medium for hematopoietic progenitor cell culture

Irvine Scientific launches new xeno-free medium for hematopoietic progenitor cell culture

19 May 2017

New medium designed for hematopoietic cell culture for cell-based therapies.

Read more 
Merck's CHOZN expression system selected for bi-specific antibody development by SystImmune

Merck's CHOZN expression system selected for bi-specific antibody development by SystImmune

18 May 2017

Accelerates development timelines with faster, easier selection and scale up of clones.

Read more 
CPhI Worldwide to launch global pharma market ranking index

CPhI Worldwide to launch global pharma market ranking index

18 May 2017

Research used to produce a global ranking of countries’ pharma reputation, market growth potential, innovation and competitiveness.

Read more 
SGS expands stability capacity at Mississauga, Canada laboratory

SGS expands stability capacity at Mississauga, Canada laboratory

17 May 2017

Expansion part of global investment in testing capabilities.

Read more